Rite Aid Allergy Relief Fexofenadine tablets recalled for impurity
Perrigo Company PLC is recalling Rite Aid Allergy Relief Fexofenadine Hydrochloride 180mg tablets nationwide due to failed impurity specifications. An out-of-specification result for impurity A was found during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a failed impurity specification with no reported illnesses or injuries. The hazard is a potential quality defect discovered through stability testing, which constitutes a moderate precautionary recall under the rubric criteria.
Plain-English summary
Perrigo Company PLC is recalling Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 24HR, 180mg. The recall affects 44,688 containers distributed nationwide in the USA.
The recall was initiated because an out-of-specification result was obtained for impurity A during stability testing, indicating the product failed impurity and degradation specifications.
Two package sizes are affected: 30-count bottles (NDC 11822-0571-2) and 150-count bottles (NDC 11822-0571-5). Affected lot numbers and expiration dates are: Lot 1BR0462 (Exp 10/31/2022), Lot 0GR0528 (Exp 3/31/2022), Lot 0KR0473 (Exp 4/30/2022), and Lot 0LR0369 (Exp 6/30/2022). The product was manufactured in the Czech Republic and distributed by Rite Aid.
Consumers should discontinue use of the affected lots and consult with their healthcare provider. The product was distributed nationwide.
The recalled product
- Product
- Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine, packaged as a) 30 count bottle, NDC 11822-0571-2 UPC 0 11822 99908 3; b) 150 count bottle, NDC 11822-0571-5 UPC 0 11822 85411 5; Made in the Czech Republic, Distributed by Rite Aid 30 Hunter
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Antihistamine / Impurity
- Affected units
- 44,688
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot # a) 1BR0462
- Exp 10/31/2022 b) 0GR0528
- Exp 3/31/2022
- 0KR0473
- Exp 4/30/2022
- 0LR0369
- Exp 6/30/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity specification failure
See all →- ModerateBerkley Jensen Fexofenadine Tablets Recalled for Impurity Specification Failure
FDA (Drugs) · 2022-01-12
- ModerateTopCare Allergy Relief Fexofenadine tablets recalled for impurity specifications
FDA (Drugs) · 2022-01-12
- ModerateAllergyrelief Fexofenadine Tablets Recalled for Impurity Specification Failure
FDA (Drugs) · 2022-01-12
- LowCandesartan Cilexetil tablets recalled for impurity specification failure
FDA (Drugs) · 2021-09-22
- LowFemtrace 0.45 mg Tablets Recalled for Moisture Ingress
FDA (Drugs) · 2013-02-06